IBERSOL SGPS SA (IBS.LS) Stock Fundamental Analysis
Europe - ELI:IBS - PTIBS0AM0008 - Common Stock
10.05 EUR
0 (0%)
Overall IBS gets a fundamental rating of 4 out of 10. We evaluated IBS against 53 industry peers in the Hotels, Restaurants & Leisure industry. IBS has only an average score on both its financial health and profitability. IBS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
IBS had positive earnings in the past year.
In the past year IBS had a positive cash flow from operations.
Of the past 5 years IBS 4 years were profitable.
IBS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
IBS has a Return On Assets (1.51%) which is comparable to the rest of the industry.
IBS has a Return On Equity (3.42%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 3.81%, IBS is in line with its industry, outperforming 47.17% of the companies in the same industry.
IBS had an Average Return On Invested Capital over the past 3 years of 3.32%. This is significantly below the industry average of 11.50%.
The 3 year average ROIC (3.32%) for IBS is below the current ROIC(3.81%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 3.42% | ||
| ROIC | 3.81% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of IBS (2.07%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of IBS has declined.
Looking at the Operating Margin, with a value of 5.03%, IBS is in line with its industry, outperforming 47.17% of the companies in the same industry.
In the last couple of years the Operating Margin of IBS has declined.
IBS's Gross Margin of 50.98% is in line compared to the rest of the industry. IBS outperforms 54.72% of its industry peers.
IBS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.03% | ||
| PM (TTM) | 2.07% | ||
| GM | 50.98% |
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IBS is destroying value.
IBS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, IBS has more shares outstanding
Compared to 1 year ago, IBS has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.01 indicates that IBS is not a great score, but indicates only limited risk for bankruptcy at the moment.
IBS's Altman-Z score of 2.01 is fine compared to the rest of the industry. IBS outperforms 66.04% of its industry peers.
The Debt to FCF ratio of IBS is 4.26, which is a neutral value as it means it would take IBS, 4.26 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of IBS (4.26) is better than 71.70% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that IBS is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.71, IBS is doing good in the industry, outperforming 69.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 4.26 | ||
| Altman-Z | 2.01 |
ROIC/WACC0.61
WACC6.21%
2.3 Liquidity
A Current Ratio of 0.96 indicates that IBS may have some problems paying its short term obligations.
IBS has a better Current ratio (0.96) than 60.38% of its industry peers.
A Quick Ratio of 0.87 indicates that IBS may have some problems paying its short term obligations.
The Quick ratio of IBS (0.87) is better than 60.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
The earnings per share for IBS have decreased strongly by -30.51% in the last year.
IBS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.23% yearly.
The Revenue has grown by 17.65% in the past year. This is quite good.
The Revenue has been decreasing by -0.46% on average over the past years.
EPS 1Y (TTM)-30.51%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%100%
Revenue 1Y (TTM)17.65%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%18.09%
3.2 Future
Based on estimates for the next years, IBS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.15% on average per year.
Based on estimates for the next years, IBS will show a small growth in Revenue. The Revenue will grow by 6.73% on average per year.
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y18.15%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.73%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 38.65, the valuation of IBS can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as IBS.
IBS is valuated rather expensively when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 23.55, IBS is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IBS is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of IBS to the average of the S&P500 Index (22.53), we can say IBS is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.65 | ||
| Fwd PE | 23.55 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, IBS is valued a bit cheaper than 79.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.89 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as IBS's earnings are expected to grow with 20.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.36%
EPS Next 3Y20.34%
5. Dividend
5.1 Amount
IBS has a Yearly Dividend Yield of 7.01%, which is a nice return.
IBS's Dividend Yield is rather good when compared to the industry average which is at 3.22. IBS pays more dividend than 100.00% of the companies in the same industry.
IBS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.01% |
5.2 History
On average, the dividend of IBS grows each year by 48.65%, which is quite nice.
Dividend Growth(5Y)48.65%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IBS pays out 268.99% of its income as dividend. This is not a sustainable payout ratio.
The dividend of IBS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP268.99%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
ELI:IBS (11/4/2025, 5:29:51 PM)
10.05
0 (0%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners21.88%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap417.18M
Revenue(TTM)511.65M
Net Income(TTM)10.61M
Analysts83.33
Price Target11.82 (17.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.01% |
Yearly Dividend0.49
Dividend Growth(5Y)48.65%
DP268.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.24%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)11.28%
Revenue beat(4)3
Avg Revenue beat(4)8.29%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)12.41%
Revenue beat(8)7
Avg Revenue beat(8)6.42%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-72.41%
EPS NY rev (1m)0%
EPS NY rev (3m)-36.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)18.9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.65 | ||
| Fwd PE | 23.55 | ||
| P/S | 0.82 | ||
| P/FCF | 5.89 | ||
| P/OCF | 3.58 | ||
| P/B | 1.34 | ||
| P/tB | 1.97 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.26
EY2.59%
EPS(NY)0.43
Fwd EY4.25%
FCF(TTM)1.71
FCFY16.99%
OCF(TTM)2.81
OCFY27.95%
SpS12.33
BVpS7.47
TBVpS5.09
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 3.42% | ||
| ROCE | 4.85% | ||
| ROIC | 3.81% | ||
| ROICexc | 4.93% | ||
| ROICexgc | 6.48% | ||
| OM | 5.03% | ||
| PM (TTM) | 2.07% | ||
| GM | 50.98% | ||
| FCFM | 13.85% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
ROICexc(3y)5.24%
ROICexc(5y)N/A
ROICexgc(3y)7.05%
ROICexgc(5y)N/A
ROCE(3y)4.21%
ROCE(5y)N/A
ROICexgc growth 3Y-24.94%
ROICexgc growth 5Y-3.32%
ROICexc growth 3Y-22.88%
ROICexc growth 5Y-3.24%
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
F-Score6
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 4.26 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 8.93% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 667.98% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 2.01 |
F-Score6
WACC6.21%
ROIC/WACC0.61
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.76%
Cap/Sales(5y)11.65%
Profit Quality(3y)200.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.51%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%100%
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y18.15%
Revenue 1Y (TTM)17.65%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%18.09%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.73%
EBIT growth 1Y19.24%
EBIT growth 3Y-20.54%
EBIT growth 5Y-7.19%
EBIT Next Year434.69%
EBIT Next 3Y84.16%
EBIT Next 5Y57.26%
FCF growth 1Y26.38%
FCF growth 3Y-0.14%
FCF growth 5Y-9.32%
OCF growth 1Y23.94%
OCF growth 3Y1.82%
OCF growth 5Y-6.35%
IBERSOL SGPS SA / IBS.LS FAQ
What is the ChartMill fundamental rating of IBERSOL SGPS SA (IBS.LS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to IBS.LS.
What is the valuation status for IBS stock?
ChartMill assigns a valuation rating of 2 / 10 to IBERSOL SGPS SA (IBS.LS). This can be considered as Overvalued.
Can you provide the profitability details for IBERSOL SGPS SA?
IBERSOL SGPS SA (IBS.LS) has a profitability rating of 4 / 10.
Can you provide the financial health for IBS stock?
The financial health rating of IBERSOL SGPS SA (IBS.LS) is 4 / 10.
What is the earnings growth outlook for IBERSOL SGPS SA?
The Earnings per Share (EPS) of IBERSOL SGPS SA (IBS.LS) is expected to decline by -16.54% in the next year.